Trial Outcomes & Findings for Radiation Therapy for Heterotopic Ossification Prophylaxis Acutely After Elbow Trauma (NCT NCT00991887)

NCT ID: NCT00991887

Last Updated: 2022-04-21

Results Overview

Mayo Elbow Performance Score (MEPS) is an outcome tool based on a 100 point scale, with higher score indicating better function. It measures pain, stability, function, and motion. The score is graded on the basis of the MEPS as excellent (\>=90), good (75-89), fair (60-74), and poor (\<60).

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

48 participants

Primary outcome timeframe

6 month

Results posted on

2022-04-21

Participant Flow

Participant milestones

Participant milestones
Measure
No Radiation Therapy (XRT)
This group will not receive radiation therapy after surgery.
Radiation Therapy (XRT)
Radiotherapy will be administered no later than 72 hours postoperatively by a board-certified radiation oncologist. It was given as a single fraction at a dose of 700 cGy at 6-MeV energy photons with use of AP-PA (anteroposterior-posterioanterior) field calculated to midplane, with a mean window of 12x8.2cm, for all patients.
Overall Study
STARTED
26
22
Overall Study
COMPLETED
24
21
Overall Study
NOT COMPLETED
2
1

Reasons for withdrawal

Reasons for withdrawal
Measure
No Radiation Therapy (XRT)
This group will not receive radiation therapy after surgery.
Radiation Therapy (XRT)
Radiotherapy will be administered no later than 72 hours postoperatively by a board-certified radiation oncologist. It was given as a single fraction at a dose of 700 cGy at 6-MeV energy photons with use of AP-PA (anteroposterior-posterioanterior) field calculated to midplane, with a mean window of 12x8.2cm, for all patients.
Overall Study
Lost to Follow-up
2
1

Baseline Characteristics

Radiation Therapy for Heterotopic Ossification Prophylaxis Acutely After Elbow Trauma

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
No Radiation Therapy (XRT)
n=26 Participants
This group will not receive radiation therapy after surgery.
Radiation Therapy (XRT)
n=22 Participants
Radiotherapy will be administered no later than 72 hours postoperatively by a board-certified radiation oncologist. It was given as a single fraction at a dose of 700 cGy at 6-MeV energy photons with use of AP-PA (anteroposterior-posterioanterior) field calculated to midplane, with a mean window of 12x8.2cm, for all patients.
Total
n=48 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
26 Participants
n=5 Participants
22 Participants
n=7 Participants
48 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
45 years
STANDARD_DEVIATION 15 • n=5 Participants
44 years
STANDARD_DEVIATION 17 • n=7 Participants
45 years
STANDARD_DEVIATION 17 • n=5 Participants
Sex: Female, Male
Female
15 Participants
n=5 Participants
7 Participants
n=7 Participants
22 Participants
n=5 Participants
Sex: Female, Male
Male
11 Participants
n=5 Participants
15 Participants
n=7 Participants
26 Participants
n=5 Participants
Region of Enrollment
United States
26 participants
n=5 Participants
22 participants
n=7 Participants
48 participants
n=5 Participants

PRIMARY outcome

Timeframe: 6 month

Population: Patients with elbow trauma treated with radiation therapy in the prevention of post-traumatic heterotopic ossification. Subjects are randomized to either radiation therapy or no radiation therapy.

Mayo Elbow Performance Score (MEPS) is an outcome tool based on a 100 point scale, with higher score indicating better function. It measures pain, stability, function, and motion. The score is graded on the basis of the MEPS as excellent (\>=90), good (75-89), fair (60-74), and poor (\<60).

Outcome measures

Outcome measures
Measure
No Radiation Therapy (XRT)
n=24 Participants
This group will not receive radiation therapy after surgery.
Radiation Therapy (XRT)
n=21 Participants
Radiotherapy will be administered no later than 72 hours postoperatively by a board-certified radiation oncologist. It was given as a single fraction at a dose of 700 cGy at 6-MeV energy photons with use of AP-PA (anteroposterior-posterioanterior) field calculated to midplane, with a mean window of 12x8.2cm, for all patients.
Mayo Elbow Performance Score
66 units on a scale
Standard Deviation 23
69 units on a scale
Standard Deviation 19

Adverse Events

No Radiation Therapy (XRT)

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

Radiation Therapy (XRT)

Serious events: 0 serious events
Other events: 8 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
No Radiation Therapy (XRT)
n=24 participants at risk
This group will not receive radiation therapy after surgery.
Radiation Therapy (XRT)
n=21 participants at risk
Radiotherapy will be administered no later than 72 hours postoperatively by a board-certified radiation oncologist. It was given as a single fraction at a dose of 700 cGy at 6-MeV energy photons with use of AP-PA (anteroposterior-posterioanterior) field calculated to midplane, with a mean window of 12x8.2cm, for all patients.
Musculoskeletal and connective tissue disorders
Fracture Nonunion
16.7%
4/24 • Number of events 4
38.1%
8/21 • Number of events 8

Additional Information

Rachel Seymour, PhD

Carolinas Medical Center

Phone: 704-355-6969

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place